RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/28032602http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28032602http://www.w3.org/2000/01/rdf-schema#comment"Lung cancer patients with anaplastic lymphoma kinase (ALK) rearrangements are candidates for targeted therapeutics. However, patients must be tested with a companion diagnostic assay to realize their ALK rearrangement status. We analyzed the publicly available E-GEOD-31210 microarray dataset and identified a non-coding RNA, sweyjawbu, which is strongly associated with ALK rearrangements. We validated these results using quantitative real-time PCR in an independent cohort consisting of 4 cell lines and 83 clinical samples. We could differentiate between ALK rearrangement-positive and -negative lung cancer samples by comparing sweyjawbu expression. Additionally, ALK rearrangement status was determined by comparing the expression of the 5' and 3' regions of the ALK transcript or by detecting known ALK hybrid subtypes. Thus, using our homebrew PCR assay, we were able to accurately detect ALK rearrangements, which could be used for diagnostic screening of lung cancer patients. The prototype could potentially be transferred to an automatic multiplex PCR platform (FilmArray) to differentiate between ALK rearrangement-positive and -negative patients in point-of-care settings."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.org/dc/terms/identifier"doi:10.18632/oncotarget.13886"xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Chang J."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Liu F."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Lu Y."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Shen J."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Wang J."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Wang Q."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Zhang Z."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Yu H."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Meng X."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Zhai Q."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/author"Ye X."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/name"Oncotarget"xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/pages"7722-7728"xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/title"Detection of ALK rearrangements in lung cancer patients using a homebrew PCR assay."xsd:string
http://purl.uniprot.org/citations/28032602http://purl.uniprot.org/core/volume"8"xsd:string
http://purl.uniprot.org/citations/28032602http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28032602
http://purl.uniprot.org/citations/28032602http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/28032602
http://purl.uniprot.org/uniprot/#_A0A0K2YUJ3-mappedCitation-28032602http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28032602
http://purl.uniprot.org/uniprot/#_D1MAM4-mappedCitation-28032602http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28032602
http://purl.uniprot.org/uniprot/#_D1MAM5-mappedCitation-28032602http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28032602
http://purl.uniprot.org/uniprot/#_B2MXD7-mappedCitation-28032602http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28032602